Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead won’t have to pay $200 million in patent case because Merck lawyer lied
Stat
Wed, 06/8/16 - 09:38 am
Tags:
Gilead Sciences, patents, Merck, hepatitis C, Sovaldi, Harvoni
Biotech Stocks: Much Ado About Nothing at ASCO?
Barron's
Mon, 06/6/16 - 11:30 pm
Tags:
ASCO 2016, biotech, Celgene, Amgen, Regeneron, Gilead Sciences
Washington Ordered to Cover Hepatitis C Drugs During Lawsuit
Bloomberg
Fri, 05/27/16 - 10:54 pm
Tags:
hepatitis C, Washington, Medicaid, Harvoni, Sovaldi, Gilead Sciences
Gilead Subpoenaed as Feds Probe Drugmaker-Charity Connections
Bloomberg
Fri, 05/27/16 - 12:40 pm
Tags:
Gilead Sciences, non-profits, Biogen, Jazz Pharmaceuticals
7 Companies in the Fight to Defeat the Zika Virus
24/7 Wall St
Thu, 05/26/16 - 09:56 am
Tags:
Zika virus, R&D, Gilead Sciences, Inovio, Intrexon, NewLink Genetics, Quest Diagnostics, Sanofi
Medivation: Three Biotech Giants Enter. Which One Leaves?
Barron's
Thu, 05/26/16 - 09:52 am
Tags:
Medivation, Sanofi, Celgene, Gilead Sciences, M&A
Hostile Sanofi puts forth its slate of Medivation directors as Gilead, Celgene weigh their own bids
Fierce Pharma
Thu, 05/26/16 - 09:50 am
Tags:
Sanofi, Medivation, Celgene, Gilead Sciences, M&A, hostile takeover
Gilead Sciences HIV Franchise Can Perform Better Than Expected
Bidness, ETC
Mon, 05/23/16 - 07:09 pm
Tags:
Gilead Sciences, HIV
Gilead Sciences: It’s More Than Hepatitis C…But Not Enough More For Now
Barron's
Sun, 05/22/16 - 11:39 am
Tags:
hepatitis C, Gilead Sciences, HIV, Genvoya, Stribild
Gilead Sciences’ Big Growth Opportunity for 2016 Is HCV
Yahoo/Market Realist
Thu, 05/19/16 - 09:41 am
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Harvoni
Behind Gilead Sciences’ Pricing Pressures for HCV Drugs in the US
Yahoo/Market Realist
Thu, 05/12/16 - 09:47 am
Tags:
Gilead Sciences, hepatitis C, drug pricing, Harvoni, Sovaldi
Merck May Need More Than Just Bolt-On Acquisitions
Seeking Alpha
Thu, 05/12/16 - 09:45 am
Tags:
Merck, AbbVie, Bristol-Myers Squibb, Pfizer, Gilead Sciences, M&A
Inside Gilead Sciences’ Active Involvement in Drugs for NASH
Yahoo/Market Realist
Thu, 05/12/16 - 09:44 am
Tags:
Gilead Sciences, NASH, simtuzumab, GS-4997, GS-9674
Big biopharma execs really just want to talk about biotech deals
Fierce Biotech
Tue, 05/10/16 - 05:06 pm
Tags:
M&A, biotech, Gilead Sciences, Allergan, Merck, Sanofi, Pfizer
India awards Gilead patent for Sovaldi, disappointing civic groups
Fierce Pharma
Tue, 05/10/16 - 10:28 am
Tags:
India, Gilead Sciences, Sovaldi
There Are Many Reasons To Be Optimistic About Gilead's Prospects
Forbes
Mon, 05/9/16 - 01:50 pm
Tags:
Gilead Sciences
Gilead Sciences: A Black Box of Uncertainty?
Barron's
Mon, 05/9/16 - 10:41 am
Tags:
Gilead Sciences
Gilead New CEO Says It's Time to Go Out and Do Important Deals
Bloomberg
Fri, 05/6/16 - 10:49 am
Tags:
Gilead Sciences, Pharma CEOs, John Milligan, M&A
What Are Analysts Saying About Q1 At Biotech's Big 4? Amgen, Biogen, Celgene, Gilead
Forbes
Sat, 04/30/16 - 11:40 am
Tags:
Amgen, Biogen, Celgene, Gilead Sciences, earnings
2 Attractive Possible Takeovers In Biotech
Seeking Alpha
Sat, 04/30/16 - 10:45 am
Tags:
M&A, biotech, Gilead Sciences, Relypsa, Ionis Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.